Jump Financial LLC cut its position in The Allstate Co. (NYSE:ALL - Free Report) by 94.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,236 shares of the insurance provider's stock after selling 98,138 shares during the period. Jump Financial LLC's holdings in Allstate were worth $1,202,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in Allstate by 5.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 577,934 shares of the insurance provider's stock worth $109,605,000 after purchasing an additional 28,584 shares during the period. Ameritas Advisory Services LLC boosted its stake in shares of Allstate by 117.3% in the fourth quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider's stock worth $944,000 after buying an additional 2,643 shares during the last quarter. Hennessy Advisors Inc. grew its holdings in Allstate by 6.9% during the fourth quarter. Hennessy Advisors Inc. now owns 58,600 shares of the insurance provider's stock worth $11,297,000 after acquiring an additional 3,800 shares during the period. Los Angeles Capital Management LLC raised its position in Allstate by 10.5% during the fourth quarter. Los Angeles Capital Management LLC now owns 508,664 shares of the insurance provider's stock valued at $98,065,000 after acquiring an additional 48,382 shares in the last quarter. Finally, Artemis Investment Management LLP lifted its holdings in Allstate by 33.3% in the fourth quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider's stock valued at $77,413,000 after acquiring an additional 100,311 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.80% of the company's stock.
Allstate Trading Up 0.2 %
ALL opened at $194.61 on Monday. The Allstate Co. has a 1-year low of $156.66 and a 1-year high of $212.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The firm has a market capitalization of $51.58 billion, a price-to-earnings ratio of 11.45, a price-to-earnings-growth ratio of 1.01 and a beta of 0.36. The company's 50 day simple moving average is $197.27 and its two-hundred day simple moving average is $194.42.
Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping analysts' consensus estimates of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. Analysts expect that The Allstate Co. will post 18.74 EPS for the current fiscal year.
Allstate announced that its board has initiated a stock buyback plan on Wednesday, February 26th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire up to 3% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's management believes its shares are undervalued.
Allstate Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th were issued a dividend of $1.00 per share. The ex-dividend date was Monday, March 10th. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.06%. Allstate's dividend payout ratio is currently 23.54%.
Wall Street Analyst Weigh In
ALL has been the subject of several recent research reports. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Barclays decreased their price objective on shares of Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. Keefe, Bruyette & Woods dropped their target price on Allstate from $240.00 to $228.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Evercore ISI raised Allstate from an "in-line" rating to an "outperform" rating in a report on Wednesday, January 8th. Finally, Wells Fargo & Company raised their price objective on Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a report on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $219.27.
Read Our Latest Stock Analysis on Allstate
Allstate Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.